SWTX SpringWorks Therapeutics Inc

For the quarter ended 31/3/2023, SpringWorks Therapeutics Inc's revenues decreased by NaN and amounted to 0.00. Net income increased by 1.02% to -73.42M. Net assets decreased by 9.18% to 506.92M and EPS increased from -1.19 to -1.18.